Advertisement

Topics

The Peanut Institute Company Profile

00:02 EDT 23rd September 2017 | BioPortfolio


News Articles [896 Associated News Articles listed on BioPortfolio]

French Biotech may also save Toddlers from Life-Threatening Peanut Allergy

The first French biotech to NASDAQ, DBV, is expanding the patient group for its promising peanut allergy treatment to include toddlers. DBV‘s Phase IIb results of its peanut allergy therapy, Vi...

Peanut Allergy: Is Oral Immunotherapy With Probiotic a Cure?

Four years after treatment stopped, some patients treated with adjuvant probiotics plus oral peanut immunotherapy in a small randomized trial continued to be unresponsive to peanut proteins. Medsca...

Les bonnes nouvelles de Viaskin Peanut

Tous les jours un bref écho des principales infos de la veille avec le remindHIER de BiotechFinances DBV Technologies (FR0010417345 – DBV), annonce le début du recrutement de son étude EPIT...

Yer Out! Baseball League Tosses Famous Snack, Wins Fans

NewsMinor League Baseball, Auvi-Q (epinephrine injection, USP) team up to keep fans with peanut allergies in the game. Peanut free-games will feature no in-park sales of peanuts or products containing...

DBV Tech Initiates Phase III Study Of Viaskin Peanut In Peanut-Allergic Patients One To Three Years Of Age

  Life Sciences Jobs   ...

DBV Technologies enrols first patient in Phase III peanut allergy trial

French biopharmaceutical firm DBV Technologies has started patient enrolment in a Phase III EPITOPE clinical trial of Viaskin Peanut to treat peanut allergy in young children.

Peanut immunotherapy provides long lasting suppression of allergy, finds study

Probiotic and peanut oral immunotherapy provides long lasting suppression of peanut allergy in children that continues for at least four years after stopping treatment, reports a long term follow-up.....

FDA OKs new peanut allergy food labels

The U.S. Food and Drug Administration announced new labels for peanut-containing foods suitable for infants this week, noting that they may reduce the risk of developing an allergy. In a statement Thu...

Drugs and Medications [44 Associated Drugs and Medications listed on BioPortfolio]

Neoceuticals [NeoStrata Company Inc]

NeoCeuticals by NeoStrata Acne Spot Treatment Gel

Blemish treatment [NeoStrata Company Inc]

Exuviance Blemish Treatment Gel

Bal in oil ampulesdimercaprol injection, usp [Taylor Pharmaceuticals]

BAL in Oil AmpulesDIMERCAPROL INJECTION, USP

Babor cleansing hy-ol [Babor Cosmetics America, Corp]

Cleansing insert

Total truth [Ole Henriksen of Denmark]

Total Truth Eye Cream SPF 15

PubMed Articles [557 Associated PubMed Articles listed on BioPortfolio]

Reduced risk of peanut sensitization following exposure through breast-feeding and early peanut introduction.

Recent trials have shown that avoiding peanuts during infancy increases the risk of peanut allergy; however, these studies did not address maternal peanut consumption.

Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: the BAMSE population-based birth cohort.

IgE signatures to peanut allergen measured in early childhood allow predicting the likelihood of peanut allergy in adolescence. Peanut symptoms and Ara h 2 IgE >2.0 ISU-E at 4 years predict peanut all...

The role of environmental exposure to peanut in the development of clinical allergy to peanut.

The presence of peanut allergy has increased over the years and still remains one of the most common causes of food-related anaphylaxis. The way in which peanut sensitization occurs has been explored,...

Sequential hypoallergenic boiled peanut and roasted peanut oral immunotherapy.

Oral immunotherapy (OIT) using roasted peanut flour can effectively desensitize peanut-allergic children [1] but is considered not to be ready for clinical practice [2] due to high rates (≥45%) of a...

Assessing food allergy risks from residual peanut protein in highly refined vegetable oil.

Refined vegetable oils including refined peanut oil are widely used in foods. Due to shared production processes, refined non-peanut vegetable oils can contain residual peanut proteins. We estimated t...

Clinical Trials [540 Associated Clinical Trials listed on BioPortfolio]

Peanut Oral Immunotherapy

This is a study in which increasing amounts of peanut flour are given to the children who are peanut allergic to desensitize them to peanut. The hypothesis is that the peanut allergic pati...

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

The study aims to assess the safety and efficacy of Viaskin Peanut to induce desensitization to peanut in peanut-allergic children 1 to 3 years of age after a 12-month treatment by EPicuta...

Early Life Origins of the Food Allergy Epidemic

The purpose of this study is to determine if avoidance of peanut by children with positive allergy testing to peanut in the first 5 years of life increases the likelihood of developing a p...

Early Peanut Introduction: Translation to Clinical Practice

The recent finding that early introduction of peanut can prevent ~70-90% of peanut allergy is a major step towards prevention of food allergy. However, because that finding was from a clin...

Peanut Sublingual Immunotherapy

The purpose of this study is to evaluate the safety and immune response to daily sublingual (under the tongue) immunotherapy (SLIT) with peanut extract in adults and children with peanut a...

Companies [1146 Associated Companies listed on BioPortfolio]

The Peanut Institute

National Peanut Board

Prota Therapeutics Pty Ltd

Prota Therapeutics is a newly established Australian private company developing immunotherapy based treatments for food allergy. The company’s lead product based on innovativ...

Aimmune Therapeutics, Inc.

Aimmune Therapeutics, Inc., founded in 2011 as Allergen Research Corporation (ARC), is a clinical-stage biopharmaceutical company developing treatments for peanut and other food a...

The Dannon Institute

The Dannon Institute is a 501c3 nonprofit foundation dedicated to non-commercial activities. Established in 1997, the Dannon Institute promotes research, education and communicati...

More Information about "The Peanut Institute" on BioPortfolio

We have published hundreds of The Peanut Institute news stories on BioPortfolio along with dozens of The Peanut Institute Clinical Trials and PubMed Articles about The Peanut Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Peanut Institute Companies in our database. You can also find out about relevant The Peanut Institute Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record